MoonLake Immunotherapeutics appoints Jorge Santos da Silva as CEO and Matthias Bodenstedt as CFO
The Company has appointed Jorge Santos da Silva as Chief Executive Officer and Matthias Bodenstedt as Chief Financial Officer.
- The Company has appointed Jorge Santos da Silva as Chief Executive Officer and Matthias Bodenstedt as Chief Financial Officer.
- Econ, Chief Operating Officer, and Prof Kristian Reich MD, PhD, Chief Scientific Officer, whose appointments were announced in May.
- Dr. Jorge Santos da Silva, Founder and CEO, commented:"Sonelokimab has the potential to transform the lives of patients affected by IL-17A/F-driven inflammatory diseases (AFID), It can offer them the chance of better disease control and that is something that moves us at MoonLake.
- Jorge Santos da Silva was previously Senior Partner at McKinsey & Company, Inc. For almost 15 years, Jorge was a leader in McKinsey's Pharmaceutical & Medical Products Practice and in the Company's Zurich office.